FI956279A - Förfaranden och mellanprodukter för framställning av 5-/2-(4-(bensoisotiazol-3-yl)-piperazin-1-yl)etyl/-6-kloro-1,3-dihydro-indol-2-on - Google Patents

Förfaranden och mellanprodukter för framställning av 5-/2-(4-(bensoisotiazol-3-yl)-piperazin-1-yl)etyl/-6-kloro-1,3-dihydro-indol-2-on Download PDF

Info

Publication number
FI956279A
FI956279A FI956279A FI956279A FI956279A FI 956279 A FI956279 A FI 956279A FI 956279 A FI956279 A FI 956279A FI 956279 A FI956279 A FI 956279A FI 956279 A FI956279 A FI 956279A
Authority
FI
Finland
Prior art keywords
formula
alkyl
compound
benzoisothiazol
dihydroindol
Prior art date
Application number
FI956279A
Other languages
English (en)
Finnish (fi)
Other versions
FI119372B (sv
FI956279A0 (sv
Inventor
Frank John Urban
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI956279A0 publication Critical patent/FI956279A0/sv
Publication of FI956279A publication Critical patent/FI956279A/sv
Application granted granted Critical
Publication of FI119372B publication Critical patent/FI119372B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI956279A 1993-06-28 1995-12-27 Förfaranden och mellanprodukter för framställning av 5-[ 2-(4-(bensoisotiazol-3-yl)-piperazin-1-yl]etyl]-6-kloro-1,3-dihydro-indol-2-on FI119372B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/083,429 US5359068A (en) 1993-06-28 1993-06-28 Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one
US8342993 1993-06-28
IB9400061 1994-04-06
PCT/IB1994/000061 WO1995000510A1 (en) 1993-06-28 1994-04-06 Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one

Publications (3)

Publication Number Publication Date
FI956279A0 FI956279A0 (sv) 1995-12-27
FI956279A true FI956279A (sv) 1995-12-27
FI119372B FI119372B (sv) 2008-10-31

Family

ID=22178273

Family Applications (1)

Application Number Title Priority Date Filing Date
FI956279A FI119372B (sv) 1993-06-28 1995-12-27 Förfaranden och mellanprodukter för framställning av 5-[ 2-(4-(bensoisotiazol-3-yl)-piperazin-1-yl]etyl]-6-kloro-1,3-dihydro-indol-2-on

Country Status (11)

Country Link
US (1) US5359068A (sv)
EP (1) EP0706524B1 (sv)
JP (1) JP2667987B2 (sv)
AT (1) ATE277041T1 (sv)
CA (1) CA2166203C (sv)
DE (1) DE69434020T2 (sv)
DK (1) DK0706524T3 (sv)
ES (1) ES2227524T3 (sv)
FI (1) FI119372B (sv)
PT (1) PT706524E (sv)
WO (1) WO1995000510A1 (sv)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3701044B2 (ja) * 1995-04-24 2005-09-28 住友精化株式会社 シアノベンゼンスルフェニルハライドおよびそれを用いる３−置換ベンゾイソチアゾールの製造方法
DK0790236T3 (da) * 1996-02-13 2004-02-23 Pfizer Prolægemidler af 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chlor-1,3-dihydro-2H-indol-2-on
TW491847B (en) 1996-05-07 2002-06-21 Pfizer Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one
PL188164B1 (pl) * 1996-05-07 2004-12-31 Pfizer Trihydrat metanosulfonianu 5-{2-[4-1,2-benzizotiazol-3-ilo)-1-piperazynylo]etylo}-6-chloro-1,3-dihydro-2H-indol-2-onu i środek farmaceutyczny
IL127497A (en) * 1997-12-18 2002-07-25 Pfizer Prod Inc Medicinal products containing piperazinyl-heterocyclic compounds for the treatment of psychiatric disorders
US6150366A (en) * 1998-06-15 2000-11-21 Pfizer Inc. Ziprasidone formulations
UY27668A1 (es) * 2002-02-20 2003-10-31 Pfizer Prod Inc Composición de ziprasidona y controles sintéticos
US20040048876A1 (en) * 2002-02-20 2004-03-11 Pfizer Inc. Ziprasidone composition and synthetic controls
AU2003260942A1 (en) * 2002-05-24 2003-12-12 Sun Pharmaceutical Industries Limited A process for the preparation of oxindole derivatives
WO2004050655A1 (en) * 2002-12-04 2004-06-17 Dr. Reddy's Laboratories Limited Polymorphic forms of ziprasidone and its hydrochloride
AU2003300814A1 (en) 2002-12-04 2004-06-23 Dr. Reddy's Laboratories Inc. Polymorphic forms of ziprasidone and its hydrochloride
WO2005016325A2 (en) * 2003-06-03 2005-02-24 Teva Pharmaceutical Industries Ltd. CRISTALLINE ZIPRASIDONE HCl AND PROCESSES FOR PREPARATION THEREOF
WO2005040160A2 (en) * 2003-10-24 2005-05-06 Teva Pharmaceutical Industries Ltd. Processes for preparation of ziprasidone
WO2005054235A1 (en) * 2003-11-28 2005-06-16 Wockhardt Limited Process for the preparing ziprasidone monohydrochloride hydrate
EP1592688A2 (en) * 2003-12-18 2005-11-09 Teva Pharmaceutical Industries Ltd. Polymorphic form b2 of ziprasidone base
CA2467538C (en) 2004-05-14 2010-08-24 Apotex Pharmachem Inc. New amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride) and processes to produce the same
CA2471219A1 (en) 2004-06-14 2005-12-14 Apotex Pharmachem Inc. Improved preparation of an anhydrate form of 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride (ziprasidone hydrochloride)
US7777037B2 (en) * 2004-10-27 2010-08-17 Dr. Reddy's Laboratories Limited Ziprasidone process
CA2593497A1 (en) * 2005-02-11 2006-08-17 Judith Aronhime Amorphous ziprasidone mesylate
US20060270685A1 (en) * 2005-03-14 2006-11-30 Judith Aronhime Anhydrous ziprasidone mesylate and a process for its preparation
CA2599391A1 (en) * 2005-03-14 2006-09-21 Teva Pharmaceutical Industries Ltd. Crystalline forms of ziprasidone mesylate
CA2621164A1 (en) * 2005-08-26 2007-03-01 Shionogi & Co., Ltd. Derivative having ppar agonistic activity
ATE549325T1 (de) 2007-01-26 2012-03-15 Basf Se 3-amino-1,2-benzisothiazol-verbindungen zur bekämpfung von tierpest ii
PL391810A1 (pl) 2010-07-14 2012-01-16 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Nowe sole ziprasidonu oraz sposoby ich otrzymywania
CN104370850B (zh) * 2013-08-14 2018-02-27 上海天慈生物谷生物工程有限公司 一种齐拉西酮关键中间体的制备方法
WO2023080193A1 (ja) * 2021-11-04 2023-05-11 日産化学株式会社 インドール化合物の製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721712A (en) * 1984-06-12 1988-01-26 Pfizer Inc. 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
US4690943A (en) * 1984-09-19 1987-09-01 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4952584A (en) * 1986-01-11 1990-08-28 Beecham Group P.L.C. 9H-pyrido[2,B-8]indole-3-carboxylic acid ester compounds having useful pharmaceutical activity
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
JPH0252042A (ja) * 1988-08-17 1990-02-21 Hitachi Plant Eng & Constr Co Ltd 空気の浄化剤及びその製造方法
US5206366A (en) * 1992-08-26 1993-04-27 Pfizer Inc. Process for preparing aryl piperazinyl-heterocyclic compounds

Also Published As

Publication number Publication date
ES2227524T3 (es) 2005-04-01
FI119372B (sv) 2008-10-31
CA2166203A1 (en) 1995-01-05
DK0706524T3 (da) 2005-01-31
FI956279A0 (sv) 1995-12-27
JP2667987B2 (ja) 1997-10-27
JPH08506354A (ja) 1996-07-09
EP0706524A1 (en) 1996-04-17
CA2166203C (en) 2001-04-24
US5359068A (en) 1994-10-25
ATE277041T1 (de) 2004-10-15
DE69434020T2 (de) 2005-09-29
WO1995000510A1 (en) 1995-01-05
DE69434020D1 (de) 2004-10-28
EP0706524B1 (en) 2004-09-22
PT706524E (pt) 2005-03-31

Similar Documents

Publication Publication Date Title
FI956279A0 (sv) Förfaranden och mellanprodukter för framställning av 5-/2-(4-(bensoisotiazol-3-yl)-piperazin-1-yl)etyl/-6-kloro-1,3-dihydro-indol-2-on
GB2263110B (en) Piperazine derivatives
MX9204008A (es) Derivados de metilen-oxindol y proceso para su preparacion.
GR3023174T3 (en) Substituted heterocyclic carboxylic acid amides, their preparation, and their use as medicaments.
DK0567271T3 (da) Steroidderivater til behandling af prostatahypertrofi, fremgangsmåde til fremstilling heraf og anvendelser heraf
ID26622A (id) Senyawa-senyawa pengganti 2-benzylamino-2-phenyl-acetamide
ZA941963B (en) Substituted (arylalkoxybenzyl)aminopropanamide derivatives and process for their preparation
AU9066498A (en) Substituted 6-alkylphenanthridines
AU544067B2 (en) Thioamides and amides. treatment of diabetes
GB9306899D0 (en) Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
ES2102327A1 (es) Nuevos derivados de 2,2,6,6-tetrametilpiperidina para utilizarse como agentes estabilizantes para materiales organicos contra la luz, el calor, y la oxidacion. n
CA2058398A1 (en) 1,4 Benzothiazine-2-Acetic Acid Derivatives, Processes for Production Thereof
DE69405760D1 (de) 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren
AU2287499A (en) Azetidinecarboxamide derivatives for treating cns disorders
HUT71512A (en) N-(3-chlorophenyl)-piperazine derivatives for producing alkyl-trazodon derivatives and process for producing them
DE69416311T2 (de) Verwendung von cephem-derivaten als antimetastatische mittel
AU686104B2 (en) Substituted amidinonaphthyl ester derivatives
HU9500953D0 (en) Process for the stereoselective synthesis of 3-substituted 2-thiomethyl propionic acids
AU2178099A (en) Azetidinecarboxamide derivatives for treating cns disorders
ES8506662A1 (es) Procedimiento para la preparacion de derivados de naftaleniltiazol
HU9401963D0 (en) Isoxazole carboxylic acid amides, process for producing them and their use

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119372

Country of ref document: FI